Development of an automated estimation of foot process width using deep learning in kidney biopsies from patients with Fabry, minimal change, and diabetic kidney diseases.

Fabry deep learning foot process foot process width machine learning podocyte

Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
27 Sep 2023
Historique:
received: 23 06 2022
revised: 06 09 2023
accepted: 15 09 2023
pubmed: 30 9 2023
medline: 30 9 2023
entrez: 29 9 2023
Statut: aheadofprint

Résumé

Podocyte injury plays a key role in pathogenesis of many kidney diseases with increased podocyte foot process width (FPW), an important measure of podocyte injury. Unfortunately, there is no consensus on the best way to estimate FPW and unbiased stereology, the current gold standard, is time consuming and not widely available. To address this, we developed an automated FPW estimation technique using deep learning. A U-Net architecture variant model was trained to semantically segment the podocyte-glomerular basement membrane interface and filtration slits. Additionally, we employed a post-processing computer vision approach to accurately estimate FPW. A custom segmentation utility was also created to manually classify these structures on digital electron microscopy (EM) images and to prepare a training dataset. The model was applied to EM images of kidney biopsies from 56 patients with Fabry disease, 15 with type 2 diabetes, 10 with minimal change disease, and 17 normal individuals. The results were compared with unbiased stereology measurements performed by expert technicians unaware of the clinical information. FPW measured by deep learning and by the expert technicians were highly correlated and not statistically different in any of the studied groups. A Bland-Altman plot confirmed interchangeability of the methods. FPW measurement time per biopsy was substantially reduced by deep learning. Thus, we have developed a novel validated deep learning model for FPW measurement on EM images. The model is accessible through a cloud-based application making calculation of this important biomarker more widely accessible for research and clinical applications.

Identifiants

pubmed: 37774924
pii: S0085-2538(23)00675-0
doi: 10.1016/j.kint.2023.09.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

David Smerkous (D)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, Washington, USA.

Michael Mauer (M)

Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Camilla Tøndel (C)

Department of Pediatrics, Haukeland University Hospital, Bergen, Norway; Institute of Clinical Medicine, University of Bergen, Bergen, Norway.

Einar Svarstad (E)

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Marie-Claire Gubler (MC)

INSERM U1163, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France.

Robert G Nelson (RG)

Chronic Kidney Disease Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, USA.

João-Paulo Oliveira (JP)

Service of Medical Genetics, São João University Hospital; Department of Medical Genetics, Faculty of Medicine and i3S-Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.

Forough Sargolzaeiaval (F)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

Behzad Najafian (B)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. Electronic address: najafian@uw.edu.

Classifications MeSH